Skip to content
10-Q

Quarterly Report

MusclePharm Corporation

0001493152-22-013900

← back to feed
Filed
May 16, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2022 · May 10, 2022 34.35M sh
Shares Diluted Q1 2022 · Mar 31, 2022 33.39M sh
Shares Diluted restated Q1 2022 · Mar 31, 2021 45.49M sh
Operating Cash Flow Q1 2022 · Mar 31, 2022 −$3.58M
Operating Cash Flow Q1 2022 · Mar 31, 2021 $98K
Cash And Equivalents Q1 2022 · Mar 31, 2022 $534K
Cash And Equivalents Q1 2022 · Dec 31, 2021 $1.22M
Stockholders Equity Q1 2022 · Mar 31, 2022 −$38.06M
Stockholders Equity Q1 2022 · Dec 31, 2021 −$32.19M
Stockholders Equity Q1 2022 · Mar 31, 2021 −$24.33M
Stockholders Equity Q1 2022 · Dec 31, 2020 −$24.42M
Current Liabilities Q1 2022 · Mar 31, 2022 $48.17M
Current Liabilities Q1 2022 · Dec 31, 2021 $40.6M
Total Liabilities Q1 2022 · Mar 31, 2022 $50.03M
Total Liabilities Q1 2022 · Dec 31, 2021 $42.92M
Current Assets Q1 2022 · Mar 31, 2022 $11.84M
Current Assets Q1 2022 · Dec 31, 2021 $10.49M
Total Assets Q1 2022 · Mar 31, 2022 $11.98M
Total Assets Q1 2022 · Dec 31, 2021 $10.73M
Eps Diluted Q1 2022 · Mar 31, 2022 −$0.19
Eps Diluted Q1 2022 · Mar 31, 2021 $0.00
Eps Basic Q1 2022 · Mar 31, 2022 −$0.19
Eps Basic Q1 2022 · Mar 31, 2021 $0.00
Net Income Q1 2022 · Mar 31, 2022 −$6.3M
Net Income Q1 2022 · Mar 31, 2021 $94K
Operating Income Q1 2022 · Mar 31, 2022 −$2.48M
Operating Income Q1 2022 · Mar 31, 2021 $272K
Gross Profit Q1 2022 · Mar 31, 2022 $1.51M
Gross Profit Q1 2022 · Mar 31, 2021 $3.69M
Cost Of Revenue Q1 2022 · Mar 31, 2022 $11.59M
Revenue Q1 2022 · Mar 31, 2022 $13.1M
Revenue Q1 2022 · Mar 31, 2021 $13.12M
Capex Q1 2022 · Mar 31, 2021 $4K